FC
RXST icon

FORA Capital’s RxSight RXST Stock Holding History

FORA Capital’s Portfolio RXST Stock Details RXST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-12,853
Closed -$167K – 646
2025
Q2 		$167K Buy
+12,853
New +$193K 0.02% 460
2024
Q3 		– Sell
-10,269
Closed -$618K – 547
2024
Q2 		$618K Sell
10,269
-1,426
-12% -$81.5K 0.08% 273
2024
Q1 		$603K Buy
11,695
+622
+6% +$30.5K 0.05% 299
2023
Q4 		$446K Buy
+11,073
New +$325K 0.04% 350

Other funds holding RXST

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
NSGL
No Street GP LP San Francisco, California $1.5B AUM 34.53% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

FORA Capital's RXST Position: Q3 2025 in Review

FORA Capital sold out of RxSight (RXST) in Q3 2025, closing a stake of 12,853 shares — an estimated $167K sold.

FORA Capital first reported a position in RXST in Q4 2023 and held it in 4 quarters. The position peaked at $618K in Q2 2024. 160 funds tracked by Wall St. Rank hold RXST as of Q3 2025.

  • FORA Capital reported no remaining RxSight position as of Q3 2025 after selling out during the quarter.
  • FORA Capital sold 12,853 RxSight shares in Q3 2025, an estimated $167K.
  • FORA Capital first reported a position in RxSight in Q4 2023 and held it in 4 quarters.
  • FORA Capital's RxSight position peaked at $618K in Q2 2024.
  • 160 funds tracked by Wall St. Rank held RxSight as of Q3 2025.

Based on FORA Capital's 13F filing for Q3 2025, filed 13 Nov 2025.